
1. Technology overview
Medimaps Group SA is a medical AI company with its headquarters in Plan-les-Ouates, Geneva, Switzerland, and offices in Copenhagen and Wilmington. Its products turn routine medical images into bone-health information, addressing under-diagnosed osteoporosis and fracture risk.
The portfolio includes TBS Osteo, which assesses bone microarchitecture from routine DXA scans, and TBS Reveal, which estimates bone fragility opportunistically from routine X-rays. The Copenhagen unit Radiobotics adds RBfracture for AI fracture detection on X-rays. Products are distributed through GE Healthcare, Hologic, Sectra, deepc, CARPL and other partners.
2. Highlighted features & specifications
- TBS Osteo: bone microarchitecture assessment from routine DXA scans.
- TBS Reveal: opportunistic bone-fragility risk from routine X-rays, CE marked under MDR.
- RBfracture: AI fracture detection on X-ray images.
- Marketplace delivery: available through CARPL, deepc, Blackford and Sectra platforms.
- CRO services: imaging analysis support for pharmaceutical clinical trials.
3. Potential application
Vietnamese hospitals and imaging centres can add bone-health screening to routine DXA exams for elderly patients. Emergency departments can use fracture detection to support X-ray reading at night. Pharma companies can use the imaging services in osteoporosis trials.
4. Benefits
Reuses images that hospitals already acquire, so no new scanning hardware is needed. Adds fracture-risk information to routine DXA and X-ray exams. Distribution through existing PACS and AI marketplaces shortens integration work. CE MDR, FDA 510(k) for TBS Osteo and ISO 13485 support regulated procurement.
5. Market trends & opportunities
Opportunistic screening, which extracts extra diagnoses from images already taken, is a growing approach as ageing populations raise osteoporosis burden. Southeast Asian hospitals with large DXA and X-ray volumes are potential users, while AI marketplaces ease deployment in PACS-based radiology.
6. Other information
Medimaps Group SA is headquartered in Plan-les-Ouates, Geneva; Radiobotics ApS is listed in Copenhagen. ISO 13485 and MDSAP certified (2026-06). TBS Osteo has FDA 510(k) clearance and CE; RBfracture has CE. The previous domain medimapsgroup.com redirects to medimaps.ai.
One platform connecting startups, corporations, research institutions, regions and investors











Playbook & Handbook · February 6, 2026
Winning Accelerator Playbook 2026 by BambuUP
RETAIL E-COMMERCE: AI AND REAL-TIME DATA ARE TRANSFORMING HOW RETAIL BUSINESSES OPERATE








































